UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Schizophrenia research, ISSN 0920-9964, 01/2008, Volume 98, Issue 1-3, pp. 79 - 83
AFRICA | DYSKINESIA | ANTIPSYCHOTIC-DRUGS | SCHIZOPHRENIA | RISK | PREVALENCE | tardive dystonia | incidence | follow-up study | UMCG Approved | population-based | 2ND-GENERATION | Follow-up study | Tardive dystonia | Population-based | Incidence | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Neurology | Biological and medical sciences | Nervous system as a whole | Medical sciences | Nervous system (semeiology, syndromes) | Data Collection - statistics & numerical data | Severity of Illness Index | Dystonic Disorders - epidemiology | Follow-Up Studies | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Dystonic Disorders - chemically induced | African Continental Ancestry Group - statistics & numerical data | Dystonic Disorders - diagnosis | Antipsychotic Agents - therapeutic use | Aged, 80 and over | Basal Ganglia Diseases - diagnosis | Adult | Female | Aged | Psychotic Disorders - drug therapy | West Indies - epidemiology | Basal Ganglia Diseases - epidemiology | Longitudinal Studies | Basal Ganglia Diseases - chemically induced | Index Medicus
Journal Article
International clinical psychopharmacology, ISSN 0268-1315, 01/2020, Volume 35, Issue 1, pp. 36 - 41
MORTALITY | epidemiology | 2ND-GENERATION ANTIPSYCHOTICS | EFFICACY | SAFETY | TOLERABILITY | clozapine | outpatients | schizophrenia | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Hypoglycemic Agents - therapeutic use | Clozapine - therapeutic use | Drug Administration Schedule | Antipsychotic Agents - adverse effects | Cardiovascular Diseases - drug therapy | Clozapine - administration & dosage | Humans | Insurance Claim Review | Middle Aged | Netherlands - epidemiology | Diabetes Mellitus - drug therapy | Male | Schizophrenia - epidemiology | Antipsychotic Agents - administration & dosage | Cardiovascular Agents - therapeutic use | Antipsychotic Agents - therapeutic use | Diabetes Mellitus - epidemiology | Cardiovascular Diseases - epidemiology | Female | Aged | Schizophrenia - drug therapy | Clozapine - adverse effects | Drug Monitoring | Health Status | Usage | Neurosciences | Databases | Schizophrenia | Hypoglycemic agents | Clozapine | Aripiprazole | Drug therapy | Health aspects | Index Medicus
Journal Article
International clinical psychopharmacology, ISSN 0268-1315, 01/2020, Volume 35, Issue 1, pp. 36 - 41
Journal Article
World psychiatry, ISSN 1723-8617, 02/2011, Volume 10, Issue 1, pp. 52 - 77
SUBSTANCE USE DISORDERS | psychotropic medication | BONE-MINERAL DENSITY | severe mental illness | schizophrenia | HUMAN-IMMUNODEFICIENCY-VIRUS | UMCG Approved | 2ND-GENERATION ANTIPSYCHOTIC-DRUGS | bipolar disorder | health disparities | HIV-RISK BEHAVIOR | Physical illness | BODY-MASS INDEX | depression | MAJOR DEPRESSIVE DISORDER | INDUCED WEIGHT-GAIN | QUALITY-OF-LIFE | CORONARY-HEART-DISEASE | Psychotropic medication | Severe mental illness | Schizophrenia | Bipolar disorder | Depression | Health disparities | Life Sciences & Biomedicine | Psychiatry | Science & Technology | WPA Educational Module
Journal Article